Intracoronary Delivery of an Adenovirus Encoding Fibroblast Growth Factor-4 in Myocardial Ischemia: Effect of Serum Antibodies and Previous Exposure to Adenovirus
- 1 February 2006
- journal article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 17 (2) , 230-238
Abstract
The presence of anti-adenoviral serotype 5 (Ad5) antibodies may limit the efficacy of Ad5-mediated gene transfer. We therefore tested the hypothesis that intracoronary delivery of an adenovirus encoding human fibroblast growth factor type 4 (Ad5.FGF4) would improve regional myocardial function in an animal model of ischemia when high antibody levels preexist or after a prior intracoronary dose of Ad5. High anti-Ad5 antibody levels were generated in pigs by subcutaneous immunization with an adenovirus encoding LacZ (Ad5.lacZ). Neutralizing antibody levels increased 648-fold (range, 82- to 2108-fold) above preimmunization levels, and persisted for the duration of the study. Myocardial function during pacing-induced ischemia was improved in the ischemic region (p<0.001) at both 2 and 4 weeks after Ad5.FGF4 administration despite the presence of preexisting antibodies to Ad5. In a second set of experiments, the efficacy of a second intracoronary administration of Ad5 was determined by exposing the animals first to an intracoronary dose of Ad5.lacZ, followed 7 weeks later by the therapeutic dose of Ad5.FGF4. After delivery of Ad5.lacZ, anti-Ad5 antibody levels increased 8-fold (range, 1- to 18-fold), but this prior exposure to Ad5 did not prevent the therapeutic effects after subsequent intracoronary dosing with Ad5.FGF4 (p<0.001). In the porcine Ameroid constrictor model of myocardial ischemia the presence of anti-Ad5 antibodies or prior intracoronary dosing with adenovirus does not prevent the ability of Ad5.FGF4, delivered by intracoronary injection, from normalizing regional myocardial function.Keywords
This publication has 33 references indexed in Scilit:
- Adenoviral Gene Transfer of FGF-5 to Hibernating Myocardium Improves Function and Stimulates Myocytes to Hypertrophy and Reenter the Cell CycleCirculation Research, 2005
- Immune responses to gene therapy vectors: influence on vector function and effector mechanismsGene Therapy, 2004
- Increased Regional Function and Perfusion After Intracoronary Delivery of Adenovirus Encoding Fibroblast Growth Factor 4: Report of Preclinical DataHuman Gene Therapy, 2004
- Absence of Germline Infection in Male Mice Following Intraventricular Injection of AdenovirusMolecular Therapy, 2001
- Immune responses to adenovirus and adeno-associated virus in humansGene Therapy, 1999
- Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirusCardiovascular Research, 1995
- Effects of dobutamine and arbutamine on regional myocardial function in a porcine model of myocardial ischemiaJACC, 1994
- Regional myocardial downregulation of the inhibitory guanosine triphosphate-binding protein (Gi alpha 2) and beta-adrenergic receptors in a porcine model of chronic episodic myocardial ischemia.Journal of Clinical Investigation, 1993
- EXPRESSION OF CLASS I AND CLASS II MAJOR HISTOCOMPATABILITY ANTIGENS IN NORMAL AND TRANSPLANTED HUMAN HEARTTransplantation, 1986
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978